Corange has announced further organisational changes at its Boehringer Mannheim and DePuy subsidiaries. The latest twist in the boardroom saga at the Bermuda-based holding company emerged on July 6th, with the news that the DePuy, CMW and ACE divisions of Corange have merged to form the DePuy Group. In a parallel move, the diagnostics and therapeutics divisions of Corange have been combined to form the Boehringer Mannheim Group.
Corange chairman Curt Engelhorn describes the adjustments as logical consequences of the recent changes to the company's board. Mr Engelhorn,...